Arovella Therapeutics (ASX: ALA) Share Price

ALA

$0.067▲+1.52%

$81.0MRank #876 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$81.0M

Volume

323K

P/E Ratio

-14.8

EPS

-$0.0016

Dividend Yield

0.00%

52-Week High

$0.125

52-Week Low

$0.065

Beta

0.063

Arovella Therapeutics (ASX: ALA) is an Australian-listed company in the Healthcare sector with a market capitalisation of $81.0M and the 876th-largest security on the ASX by market capitalisation. The ALA share price is $0.067, up 1.52% today and down 19.28% over the past 12 months. Shares have traded between $0.065 and $0.125 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Arovella Therapeutics reported revenue of $0 and a net loss of $1.9M.

Charts

$0.07

24H Range

$0.065

$0.067

52-Week Range

$0.065

$0.125

About Arovella Therapeutics Limited

Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated to developing therapeutic solutions for oncology and central nervous system afflictions, operating both domestically and internationally. Its pipeline features several key assets, including ZolpiMist, an oral spray formulation of zolpidem tartrate for the treatment of short-term insomnia, commercially known by brands such as Ambien or Stilnox. The company is also advancing an invariant natural killer T (iNKT) cell therapy platform specifically designed to target blood cancers. Furthermore, Arovella employs OroMist, an oro-mucosal technology enabling the delivery of various drug classes through absorption in the oral cavity via the cheeks, gums, tongue, or mouth floor, and is developing Anagrelide for cancer treatment. Beyond these, the company is engaged in creating oral sprays to address conditions like migraine headaches, motion sickness, and drug-resistant epilepsy. Arovella maintains a research collaboration agreement with Imperial College London. Established in 1999 and based in Osborne Park, Australia, the company was formerly known as Suda Pharmaceuticals Ltd before rebranding to Arovella Therapeutics Limited in October 2021.

IPO Date

22 Jan 2002

CEO

Michael Baker

Employees

Website

arovella.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-1.9M
Total Assets	$20.2M
Total Debt	$0
Free Cash Flow	$-1.8M
Return on Equity	-9.93%
Profit Margin	—
Operating Margin	—

ALA Frequently Asked Questions

What is the Arovella Therapeutics (ASX: ALA) share price?

The ALA share price is $0.067, up 1.52% for the day, based on the latest available ASX market data.

What is Arovella Therapeutics's market capitalisation?

Arovella Therapeutics has a market capitalisation of $81.0M, making it the 876th-largest security listed on the ASX.

Does Arovella Therapeutics pay a dividend?

ALA does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Arovella Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), ALA reported revenue of $0 and a net loss of $1.9M.

How many ALA shares are on issue?

Arovella Therapeutics has approximately 1,208,780,000 shares on issue, based on its market capitalisation of $81.0M and current share price.

What sector is Arovella Therapeutics in?

Arovella Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Arovella Therapeutics list on the ASX?

Arovella Therapeutics listed on the Australian Securities Exchange on 22 Jan 2002.

Latest News

Arovella Therapeutics Appoints CAR-T Pioneer Professor Cameron Turtle to Clinical Advisory Board Ahead of ALA-101 First-in-Human Trial

Kalkine9 June 2026

Arovella Therapeutics Appoints CAR-T Pioneer Professor Cameron Turtle to Clinical Advisory Board Ahead of ALA-101 First-in-Human Trial Kalkine

Arovella Therapeutics board changes after shareholder requisition notice

Proactive financial news4 May 2026

Arovella Therapeutics board changes after shareholder requisition notice Proactive financial news

Arovella secures FDA clearance to begin first-in-human trials of ALA-101 cell therapy

BiotechDispatch29 Jan 2026

Arovella secures FDA clearance to begin first-in-human trials of ALA-101 cell therapy BiotechDispatch

ALA:ASX Announcement - Notification of cessation of securities - ALA - 08 May 2026

Market Index8 May 2026

ALA:ASX Announcement - Notification of cessation of securities - ALA - 08 May 2026 Market Index

Arovella Therapeutics (ASX:ALA) shareholders have earned a 47% CAGR over the last three years

Yahoo Finance27 Jan 2026

Arovella Therapeutics (ASX:ALA) shareholders have earned a 47% CAGR over the last three years Yahoo Finance

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
RCERecce Pharmaceuticals Ltd	$144.6M	$0.50	-2.84	0.00%	▲+2.04%
ALCAlcidion Group Limited	$134.4M	$0.10	26.51	0.00%	–+0.00%
ACWActinogen Medical Limited	$122.0M	$0.034	-4.28	0.00%	–+0.00%
ATHAlterity Therapeutics Limited	$107.7M	$0.495	-2.12	0.00%	▲+11.24%
ILAIsland Pharmaceuticals Limited	$95.0M	$0.38	-5.66	0.00%	▲+7.04%
BIOBiome Australia Limited	$62.7M	$0.275	19.71	0.00%	–+0.00%
ATXAmplia Therapeutics Limited	$56.5M	$0.11	-8.54	0.00%	–+0.00%
IMUImugene Limited	$37.8M	$0.091	-0.70	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.066	$0.067	$0.065	$0.067	323K	▲+1.52%
11 June 2026	$0.067	$0.068	$0.065	$0.066	764K	▼-1.49%
10 June 2026	$0.067	$0.068	$0.065	$0.067	1.3M	–+0.00%
9 June 2026	$0.069	$0.069	$0.067	$0.067	999K	▼-2.90%
8 June 2026	$0.07	$0.07	$0.066	$0.069	1.1M	▲+1.47%
5 June 2026	$0.07	$0.07	$0.066	$0.068	1.1M	▼-4.23%
4 June 2026	$0.07	$0.071	$0.069	$0.071	96K	▼-1.39%
3 June 2026	$0.071	$0.072	$0.069	$0.072	449K	▲+4.35%
2 June 2026	$0.073	$0.073	$0.069	$0.069	400K	▼-4.17%
1 June 2026	$0.071	$0.073	$0.07	$0.072	612K	▲+1.41%
29 May 2026	$0.071	$0.071	$0.068	$0.071	465K	–+0.00%
28 May 2026	$0.073	$0.073	$0.07	$0.071	786K	▼-1.39%
27 May 2026	$0.073	$0.073	$0.072	$0.072	792K	▼-1.37%
26 May 2026	$0.075	$0.079	$0.073	$0.073	453K	▼-2.67%
25 May 2026	$0.072	$0.075	$0.071	$0.075	2.1M	▲+7.14%
22 May 2026	$0.07	$0.071	$0.07	$0.07	651K	▼-1.41%
21 May 2026	$0.073	$0.074	$0.071	$0.071	1.9M	▼-4.05%
20 May 2026	$0.074	$0.075	$0.074	$0.074	279K	–+0.00%
19 May 2026	$0.075	$0.076	$0.074	$0.074	740K	▼-1.33%
18 May 2026	$0.074	$0.078	$0.074	$0.075	906K	–+0.00%
15 May 2026	$0.075	$0.075	$0.074	$0.075	448K	▲+1.35%
14 May 2026	$0.075	$0.075	$0.072	$0.074	275K	▲+1.37%
13 May 2026	$0.073	$0.074	$0.072	$0.073	294K	–+0.00%
12 May 2026	$0.075	$0.075	$0.073	$0.073	286K	▼-2.67%
11 May 2026	$0.075	$0.077	$0.075	$0.075	771K	▼-1.32%
8 May 2026	$0.075	$0.078	$0.075	$0.076	839K	▲+1.33%
7 May 2026	$0.074	$0.079	$0.074	$0.075	2.1M	▲+5.63%
6 May 2026	$0.068	$0.075	$0.068	$0.071	2.2M	▲+4.41%
5 May 2026	$0.069	$0.069	$0.066	$0.068	3.6M	▼-4.23%
4 May 2026	$0.08	$0.08	$0.07	$0.071	6.5M	▼-8.97%

About Arovella Therapeutics Limited

IPO Date

22 Jan 2002

CEO

Michael Baker

Employees

Website

arovella.com

ALA Frequently Asked Questions

What is the Arovella Therapeutics (ASX: ALA) share price?

The ALA share price is $0.067, up 1.52% for the day, based on the latest available ASX market data.

What is Arovella Therapeutics's market capitalisation?

Arovella Therapeutics has a market capitalisation of $81.0M, making it the 876th-largest security listed on the ASX.

Does Arovella Therapeutics pay a dividend?

ALA does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Arovella Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), ALA reported revenue of $0 and a net loss of $1.9M.

How many ALA shares are on issue?

Arovella Therapeutics has approximately 1,208,780,000 shares on issue, based on its market capitalisation of $81.0M and current share price.

What sector is Arovella Therapeutics in?

Arovella Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Arovella Therapeutics list on the ASX?

Arovella Therapeutics listed on the Australian Securities Exchange on 22 Jan 2002.

Company

Market Cap

Price

P/E

Div Yield

1D Change

RCERecce Pharmaceuticals Ltd

$144.6M

$0.50

-2.84

0.00%

▲+2.04%

ALCAlcidion Group Limited

$134.4M

$0.10

26.51

0.00%

–+0.00%

ACWActinogen Medical Limited

$122.0M

$0.034

-4.28

0.00%

–+0.00%

ATHAlterity Therapeutics Limited

$107.7M

$0.495

-2.12

0.00%

▲+11.24%

ILAIsland Pharmaceuticals Limited

$95.0M

$0.38

-5.66

0.00%

▲+7.04%

BIOBiome Australia Limited

$62.7M

$0.275

19.71

0.00%

–+0.00%

ATXAmplia Therapeutics Limited

$56.5M

$0.11

-8.54

0.00%

–+0.00%

IMUImugene Limited

$37.8M

$0.091

-0.70

0.00%

–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.066	$0.067	$0.065	$0.067	323K	▲+1.52%
11 June 2026	$0.067	$0.068	$0.065	$0.066	764K	▼-1.49%
10 June 2026	$0.067	$0.068	$0.065	$0.067	1.3M	–+0.00%
9 June 2026	$0.069	$0.069	$0.067	$0.067	999K	▼-2.90%
8 June 2026	$0.07	$0.07	$0.066	$0.069	1.1M	▲+1.47%
5 June 2026	$0.07	$0.07	$0.066	$0.068	1.1M	▼-4.23%
4 June 2026	$0.07	$0.071	$0.069	$0.071	96K	▼-1.39%
3 June 2026	$0.071	$0.072	$0.069	$0.072	449K	▲+4.35%
2 June 2026	$0.073	$0.073	$0.069	$0.069	400K	▼-4.17%
1 June 2026	$0.071	$0.073	$0.07	$0.072	612K	▲+1.41%
29 May 2026	$0.071	$0.071	$0.068	$0.071	465K	–+0.00%
28 May 2026	$0.073	$0.073	$0.07	$0.071	786K	▼-1.39%
27 May 2026	$0.073	$0.073	$0.072	$0.072	792K	▼-1.37%
26 May 2026	$0.075	$0.079	$0.073	$0.073	453K	▼-2.67%
25 May 2026	$0.072	$0.075	$0.071	$0.075	2.1M	▲+7.14%
22 May 2026	$0.07	$0.071	$0.07	$0.07	651K	▼-1.41%
21 May 2026	$0.073	$0.074	$0.071	$0.071	1.9M	▼-4.05%
20 May 2026	$0.074	$0.075	$0.074	$0.074	279K	–+0.00%
19 May 2026	$0.075	$0.076	$0.074	$0.074	740K	▼-1.33%
18 May 2026	$0.074	$0.078	$0.074	$0.075	906K	–+0.00%
15 May 2026	$0.075	$0.075	$0.074	$0.075	448K	▲+1.35%
14 May 2026	$0.075	$0.075	$0.072	$0.074	275K	▲+1.37%
13 May 2026	$0.073	$0.074	$0.072	$0.073	294K	–+0.00%
12 May 2026	$0.075	$0.075	$0.073	$0.073	286K	▼-2.67%
11 May 2026	$0.075	$0.077	$0.075	$0.075	771K	▼-1.32%
8 May 2026	$0.075	$0.078	$0.075	$0.076	839K	▲+1.33%
7 May 2026	$0.074	$0.079	$0.074	$0.075	2.1M	▲+5.63%
6 May 2026	$0.068	$0.075	$0.068	$0.071	2.2M	▲+4.41%
5 May 2026	$0.069	$0.069	$0.066	$0.068	3.6M	▼-4.23%
4 May 2026	$0.08	$0.08	$0.07	$0.071	6.5M	▼-8.97%